KRAS MUTATION, CODON 12 & 13 FRAGMENT ANALYSIS

KRAS mutation testing is recommended prior to initiation of EGFR targeted therapy in Colorectal carcinoma. Absence of detectable KRAS mutation within the tumor suggests that this patient may respond to such therapies.

  • Test Type:
  • Pre-test Information:
    Clinical history & Histopathology report is mandatory.
  • Report Delivery:
    Sample by Tue 11 am; Report Mon
  • Components:
    0

Sample Report

kras mutation codon 12 & 13 fragments in other Cities